MANNING JOSEPH J 4
4 · ABBOTT LABORATORIES · Filed Feb 23, 2021
Insider Transaction Report
Form 4
MANNING JOSEPH J
Senior Vice President
Transactions
- Award
Option (right to buy)
2021-02-19+66,658→ 66,658 totalExercise: $124.04From: 2022-02-19Exp: 2031-02-18→ Common Shares (66,658 underlying) - Award
Common shares without par value
2021-02-19+13,004→ 61,707 total
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Since the date of the reporting person's last ownership report, he transferred 10,978 shares and employee stock options to purchase shares 178,060 in the aggregate to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 22,219 on February 19, 2022, 22,219 on February 19, 2023, and 22,220 on February 19, 2024.